PDCD1 and cancer: In 2018, the Nobel Prize in Physiology or Medicine was awarded to Tasuku Honjo and James P. Allison (3) for their contribution in discovering cancer therapy by inhibiting programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte antigen 4 (CTLA-4), respectively.